Fibromyalgia and Chronic Fatigue Syndrome (CFS) are complex, often debilitating chronic conditions that affect millions of women and men worldwide. While the exact causes remain elusive, the conditions are thought to arise out of a toxicity (usually heavy metals), previous viral infection (e.g., Epstein Barr Virus and Lyme Disease), and gut dysbiosis.

While the metabolic approach to cancer is still in its early stages, it offers a promising avenue for future research and treatment options. By targeting the metabolic vulnerabilities of cancer cells, we may be able to develop more effective and less toxic therapies. Understanding cancer as a metabolic disease is not only changing how we perceive this complex illness but also holds the potential to revolutionize the way we approach its prevention and treatment in the years to come.